The adenosine analogue N6-L-phenylisopropyladenosine inhibits catecholamine secretion from bovine adrenal medulla cells by inhibiting calcium influx

J Neurochem. 1992 Oct;59(4):1399-404. doi: 10.1111/j.1471-4159.1992.tb08453.x.

Abstract

We reported earlier that adenine nucleotides and adenosine inhibit acetylcholine-induced catecholamine secretion from bovine adrenal medulla chromaffin cells. In this article, we used an adenosine analogue, N6-L-phenylisopropyladenosine (PIA), to study the mechanism underlying inhibition of catecholamine secretion by adenosine. PIA inhibits secretion induced by a nicotinic agonist, 1,1-dimethyl-4-phenylpiperazinium, or by elevated external K+. The half-maximal effect on 1,1-dimethyl-4-phenylpiperazinium-induced secretion occurred at approximately 5 x 10(-5) M. The inhibition is immediate and reversible. Fura-2 measurements of cytosolic free Ca2+ indicate that PIA inhibits Ca2+ elevation caused by stimulation; measurements of 45Ca2+ influx show that PIA inhibits uptake of Ca2+. PIA does not inhibit calcium-evoked secretion from digitonin-permeabilized cells, nor does PIA cause any significant change in the dependence of catecholamine secretion on calcium concentration. These data suggest that inhibition by PIA occurs at the level of the voltage-sensitive calcium channel.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Medulla / cytology
  • Adrenal Medulla / metabolism*
  • Animals
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology*
  • Catecholamines / metabolism*
  • Cattle
  • Cells, Cultured
  • Dimethylphenylpiperazinium Iodide / pharmacology
  • GTP-Binding Proteins / physiology
  • Phenylisopropyladenosine / pharmacology*
  • Potassium / pharmacology
  • Time Factors

Substances

  • Calcium Channel Blockers
  • Catecholamines
  • Phenylisopropyladenosine
  • Dimethylphenylpiperazinium Iodide
  • GTP-Binding Proteins
  • Potassium
  • Calcium